Trading Places—Switching Frataxin Function by a Single Amino Acid Substitution within the [Fe-S] Cluster Assembly Scaffold

article has not abstract

Published in the journal: . PLoS Genet 11(5): e32767. doi:10.1371/journal.pgen.1005192
Category: Perspective
doi: 10.1371/journal.pgen.1005192


article has not abstract

Simple inorganic structures comprised of iron and sulfur are called [Fe-S] clusters. They likely represent one of the earliest prosthetic groups associated with the emergence of life on earth and continue to have essential roles in sustaining many metabolic processes in almost all existing life forms. For example, proteins that contain one or more [Fe-S] clusters, generally referred to as [Fe-S] proteins, are involved in a wide variety of important cellular functions, including energy transformations, catalysis, and regulation of gene expression. In recent years, the assembly of [Fe-S] clusters and their trafficking within biological systems has captured the attention of researchers because defects in the process can lead to disruption of important metabolic processes, which, in humans, is often manifested in a variety of pathological conditions [1].

Two central players involved in biological [Fe-S] cluster formation include an L-cysteine desulfurase (designated IscS in bacteria or Nfs1 in eukaryotes) and an assembly scaffold (designated IscU in bacteria or Isu in eukaryotes). IscS/Nfs1 delivers S in the form of an enzyme-bound persulfide to IscU/Isu upon which nascent [Fe-S] clusters are formed prior to their delivery to target proteins or intermediate carriers (Fig 1) [24]. Given the early evolutionary emergence of [Fe-S] clusters, as well as their critical metabolic function, it is not surprising that the primary structures and mechanistic features of the IscS/Nfs and IscU/Isu orthologs are conserved throughout nature. Nevertheless, some fundamental differences between the prokaryotic and eukaryotic systems have become apparent. For example, the eukaryotic Nfs L-cysteine desulfurase requires an additional subunit, Isd11 [5], for basal activity, but the bacterial ortholog IscS does not [6].

Frataxin involvement in [Fe-S] cluster biogenesis in <i>E</i>. <i>coli</i> and <i>S</i>. <i>cerevisiae</i>.
Fig. 1. Frataxin involvement in [Fe-S] cluster biogenesis in E. coli and S. cerevisiae.
Cysteine desulfurases IscS and Nfd1/Isd11 are shown in yellow, and the frataxin orthologs CyaY and Yfh1 are shown in red. The wild-type scaffold proteins IscU Ile108 and Isu1 Met141 are indicated in blue, while the variant proteins are in orange (IscU Met108 and Isu1 Ile141). In E. coli, CyaY has been shown to inhibit in vitro assembly of Fe-S cluster on wild-type IscU (indicated by red bar), and is required for in vivo [Fe-S] cluster biogenesis in strains containing IscU Met108 (indicated by black bar). In S. cerevisiae, Yfh1 facilitates [Fe-S] cluster assembly on the wild-type Isu1 (indicated by black bar), while a strain containing Isu1 Ile141 does not require Yfh1 for in vivo [Fe-S] cluster biogenesis.

Another difference in prokaryotic versus eukaryotic [Fe-S] cluster assembly that has confounded the research community involves the role of a protein called Frataxin (designated Fxn in humans, Yfh1 in yeast, and CyaY in bacteria) [7,8]. Frataxin has been the subject of intense investigation for many years because defects in its formation are associated with a debilitating human neurodegenerative disease known as Friedreich’s ataxia [1]. Yeast loss of Yfh1 function is linked to dysregulation of Fe homeostasis and defects in [Fe-S] cluster formation [9]. In contrast to the important function of Yfh1 in yeast, complete loss of the bacterial ortholog, CyaY, does not exhibit a profound phenotype [10,11]. These apparently contradictory results were reconciled by biochemical analyses obtained using in vitro IscS-IscU or Nfs-Isd11-Isu directed [Fe-S] cluster assembly. In these studies, it was shown that the bacterial Frataxin ortholog CyaY inhibits [Fe-S] cluster assembly by slowing IscS mediated S delivery to IscU, whereas the eukaryotic Frataxin ortholog stimulates [Fe-S] cluster assembly by acceleration of Nfs/Isd11 mediated S delivery to Isu (Fig 1) [7,12,13]. Work described in the articles by Yoon et al. [14] and Roche et al. [15] now provide remarkable in vivo complements to the pioneering biochemical studies.

Although Yfh1 inactivation causes severe metabolic defects in yeast, the Dancis group was able to isolate a fast-growing strain that bypasses the Yfh1 requirement [16]. The spontaneous suppressor mutation leading to Yfh1 independence is localized within isu1 and results in substitution of the Isu1 Met141 residue by Isu1 Ile141. This result was particularly intriguing because the Escherichia coli IscU residue corresponding to Isu Met141 is naturally occupied by IscU Ile108. Yoon et al. now report on an exhaustive study on suppression of the yeast Yfh1 deletion phenotype by using both directed mutagenesis and genetic selection strategies [14]. They find that suppression of the Yfh1 deletion phenotype can only be accomplished by substitutions at the Met141 position and only by substitution of an Ile, Leu, Cys, or Val residue. Remarkably, bioinformatic analyses reveal that these four amino acids are also, by far, the most highly represented and naturally occurring residues at this position among almost all IscU-containing prokaryotes. In contrast, examination of a vast number of eukaryotic Isu primary structures reveals that Isu Met141 is strictly conserved. A second approach that provided further evidence on the correlation between Yfh1 dependence and the Isu Met141 residue involved heterologous expression of the E. coli IscU in a yeast Yfh1 depletion strain. These experiments demonstrated that the wild-type E. coli IscU could be used to rescue the yeast phenotype associated with the lack of Yfh1, but the IscU Met108-substituted form could not.

Building on the observation that the yeast Yfh1 deletion phenotype is suppressed by substitution of Isu Met141 with the corresponding bacterial IscU Ile108 residue, Roche et al. asked the reciprocal question [15]. Namely, does substitution of the E. coli IscU Ile108 residue by Met108 render [Fe-S] cluster assembly dependent on the presence of CyaY, the bacterial ortholog of yeast Yfh1? The answer to that question is yes. Roche et al. also explored the phylogenic conservation at the IscU residue108 position as a way to gain clues into the evolutionary emergence of the Yfh1-dependent eukaryotic Isu form. Interestingly, it was found that the Rickettsia are one of very few bacteria that naturally carry an Iscu Met108. Given the endosymbiotic lifestyle of the Rickettsia, and its possible role in primordial acquisition of mitochondria, Roche et al. make the credible suggestion that the dependence of “Frataxin” for [Fe-S] cluster synthesis was acquired from bacteria, rather than independently within the established Eukaryotic lineage.

These two complementary studies have led to the amazing observation that substitution of a single amino acid carried within the ancient IscU family of proteins can lead to a profound alteration in the function of an associated accessory component, as either an activator or as an apparent inhibitor of the cluster assembly process. They also provide strong in vivo evidence to support a growing body of elegant biochemical studies that have demonstrated an important role for the Frataxin family of proteins in modulating intermolecular S-transfer during [Fe-S] cluster biosynthesis. Finally, they highlight the central importance of the IscU-type of molecular scaffold that, save for the effects of one amino acid variation, appears to have a structure and mechanism that has been conserved through time and throughout nature.


1. Rouault TA Mammalian iron-sulphur proteins: novel insights into biogenesis and function. Nat Rev Mol Cell Biol 2015;16: 45–55. doi: 10.1038/nrm3909 25425402

2. Black KA, Dos Santos PC. Shared-intermediates in the biosynthesis of thio-cofactors: Mechanism and functions of cysteine desulfurases and sulfur acceptors. Biochim Biophys Acta. 2014; epub ahead of print.

3. Stehling O, Wilbrecht C, Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie. 2014; 100: 61–77. doi: 10.1016/j.biochi.2014.01.010 24462711

4. Blanc B, Gerez C, Ollagnier de Choudens S Assembly of Fe/S proteins in bacterial systems: Biochemistry of the bacterial ISC system. Biochim Biophys Acta. 2014; epub ahead of print.

5. Wiedemann N, Urzica E, Guiard B, Muller H, Lohaus C, Meyer HE, et al. Essential role of Isd11 in mitochondrial iron-sulfur cluster synthesis on Isu scaffold proteins. EMBO J. 2006; 25: 184–195. 16341089

6. Zheng L, Cash VL, Flint DH, Dean DR Assembly of iron-sulfur clusters. Identification of an iscSUA-hscBA-fdx gene cluster from Azotobacter vinelandii. J Biol Chem. 1998; 273: 13264–13272. 9582371

7. Bridwell-Rabb J, Iannuzzi C, Pastore A, Barondeau DP. Effector role reversal during evolution: the case of frataxin in Fe-S cluster biosynthesis. Biochemistry 2012; 51: 2506–2514. doi: 10.1021/bi201628j 22352884

8. Adinolfi S, Iannuzzi C, Prischi F, Pastore C, Iametti S, Martin SR, et al. Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol. 2009; 16: 390–396. doi: 10.1038/nsmb.1579 19305405

9. Muhlenhoff U, Richhardt N, Ristow M, Kispal G, Lill R The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum Mol Genet. 2002; 11: 2025–2036. 12165564

10. Roche B, Huguenot A, Barras F, Py B. The iron-binding CyaY and IscX proteins assist the ISC-catalyzed Fe-S biogenesis in Escherichia coli. Mol Microbiol 95: 605–623. doi: 10.1111/mmi.12888 25430730

11. Vivas E, Skovran E, Downs DM (2006) Salmonella enterica strains lacking the frataxin homolog CyaY show defects in Fe-S cluster metabolism in vivo. J Bacteriol. 2015; 188: 1175–1179.

12. Parent A, Elduque X, Cornu D, Belot L, Le Caer JP, Grandas A, et al. Mammalian frataxin directly enhances sulfur transfer of NFS1 persulfide to both ISCU and free thiols. Nat Commun 2015; 6: 5686. doi: 10.1038/ncomms6686 25597503

13. Bridwell-Rabb J, Fox NG, Tsai CL, Winn AM, Barondeau DP Human frataxin activates Fe-S cluster biosynthesis by facilitating sulfur transfer chemistry. Biochemistry. 2014; 53: 4904–4913. doi: 10.1021/bi500532e 24971490

14. Yoon H, Knight SA, Pandey A, Pain J, Turkarslan S, Pain D. Turning Saccharomyces cerevisiae into a frataxin-independent organism. PLOS Genetics 2015; this issue.

15. Roche B, Agrebi R, Huguenot A, Ollagnier de Choudens S, Barras F. Turning Escherichia coli into a frataxin-depedent organism. PLOS Genetics. 2015; this issue.

16. Yoon H, Knight SA, Pandey A, Pain J, Zhang Y, Pain D, et al. Frataxin-bypassing Isu1: characterization of the bypass activity in cells and mitochondria. Biochem J. 2014; 459: 71–81. doi: 10.1042/BJ20131273 24433162

Genetika Reprodukční medicína

Článek vyšel v časopise

PLOS Genetics

2015 Číslo 5

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Zánětlivá bolest zad a axiální spondylartritida – Diagnostika a referenční strategie
nový kurz
Autoři: MUDr. Monika Gregová, Ph.D., MUDr. Kristýna Bubová

Inhibitory karboanhydrázy v léčbě glaukomu
Autoři: as. MUDr. Petr Výborný, CSc., FEBO

Krvácení v důsledku portální hypertenze při jaterní cirhóze – od pohledu záchranné služby až po závěrečný hepato-gastroenterologický pohled
Autoři: PhDr. Petr Jaššo, MBA, MUDr. Hynek Fiala, Ph.D., prof. MUDr. Radan Brůha, CSc., MUDr. Tomáš Fejfar, Ph.D., MUDr. David Astapenko, Ph.D., prof. MUDr. Vladimír Černý, Ph.D.

Rozšíření možností lokální terapie atopické dermatitidy v ordinaci praktického lékaře či alergologa
Autoři: MUDr. Nina Benáková, Ph.D.

Léčba bolesti v ordinaci praktického lékaře
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se

Nová funkce oznámení

všimli jsme si, že se zajímáte o obsah na našem webu. Využijte nové funkce zapnutí webových notifikací a nechte se informovat o nejnovějším obsahu.

Zjistit více